STAMBP and melanoma: N-p-trans-coumaroyltyramine, N-trans-feruloyltyramine, and N-trans-caffeoyltyramine exhibited anti-melanogenesis activity at 50 μM, reducing the amount of melanin produced by alpha melanocyte stimulating hormone (α-MSH) activation in B16F10 melanoma cells [85].